Perigon Wealth Management LLC grew its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 10.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,130 shares of the financial services provider’s stock after buying an additional 759 shares during the quarter. Perigon Wealth Management LLC’s holdings in MetLife were worth $698,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the business. Sanctuary Advisors LLC purchased a new stake in shares of MetLife during the 2nd quarter worth $6,377,000. Massmutual Trust Co. FSB ADV lifted its stake in shares of MetLife by 7.5% in the third quarter. Massmutual Trust Co. FSB ADV now owns 2,342 shares of the financial services provider’s stock valued at $193,000 after purchasing an additional 164 shares during the period. Czech National Bank boosted its holdings in MetLife by 5.3% during the third quarter. Czech National Bank now owns 119,837 shares of the financial services provider’s stock worth $9,884,000 after buying an additional 6,007 shares in the last quarter. Wright Investors Service Inc. increased its holdings in MetLife by 1.5% in the third quarter. Wright Investors Service Inc. now owns 21,548 shares of the financial services provider’s stock valued at $1,777,000 after buying an additional 327 shares in the last quarter. Finally, Handelsbanken Fonder AB lifted its position in shares of MetLife by 50.0% during the 3rd quarter. Handelsbanken Fonder AB now owns 109,120 shares of the financial services provider’s stock valued at $9,000,000 after acquiring an additional 36,367 shares during the period. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Stock Performance
NYSE MET opened at $86.56 on Friday. The business’s 50-day moving average price is $84.06 and its 200 day moving average price is $80.39. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a twelve month low of $64.61 and a twelve month high of $89.05. The company has a market capitalization of $59.93 billion, a PE ratio of 17.45, a price-to-earnings-growth ratio of 0.66 and a beta of 1.07.
MetLife Announces Dividend
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on MET shares. JPMorgan Chase & Co. raised their price objective on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. TD Cowen lifted their price target on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Barclays lifted their target price on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Finally, Wells Fargo & Company dropped their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday, January 14th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $90.46.
Check Out Our Latest Analysis on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Ride Out The Recession With These Dividend Kings
- Nebius Group: Market Overreaction or Real AI Disruption?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- The Best Way to Invest in Gold Is…
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.